$FUL

FULLER H B CO (FUL): Results of Operations and Financial Condition

FULLER H B CO (FUL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Worldwide Headquarters 1200 Willow Lake Boulevard St. Paul, Minnesota 55110-5101 Scott Jensen Investor Relations Contact investors@hbfuller.com NEWS September 23, 2026 H.B. Fuller Reports Third Quarter 2026 Results Net revenue of $938 million, up 5.2% year-on-year; O

Original reporting
Published Sep 24, 2026, 12:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 1:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FUL
Bullish
high confidence
Mentioned
$FUL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FULBullishHigh
01

Why it matters

The earnings beat and updated guidance may trigger short-covering and buying pressure, especially in industrial ETFs.

02

Market read

The earnings release provides fresh, material data that can influence trading decisions on FUL and related industrial stocks.

03

What to watch

Potential integration risks from the pending AMS acquisition could affect future earnings.

Relevance 7/10Novelty 8/10Timing: after-hours release on Sep 24, 2026

Background

H.B. Fuller is the largest pure-play adhesives company, reporting Q3 2026 results via an SEC Form 8‑K.

Company-level read

Ticker impact

$FULBullishHigh confidence
Context

H.B. Fuller reported Q3 2026 results with revenue up 5.2% YoY and raised its FY2026 adjusted EPS guidance to $4.70-$4.85.

Expected impact

expect modest price appreciation on the back of better-than-expected earnings and updated EPS outlook

Evidence & confidence

Revenue growth, margin expansion, and updated EPS guidance indicate improved profitability and may attract buying interest.

Market effects

Adhesives and specialty chemicals sector may see broader optimism from Fuller’s beat.

North American industrials could benefit from Fuller’s strong performance.

Global supply-chain stability concerns are mitigated by Fuller’s inventory investments.

Counterpoint

If margin expansion stalls, the stock could face pressure despite the earnings beat.

Key entities

  • Celeste Mastin

    President and CEO of H.B. Fuller, quoted on performance and upcoming acquisition.

Related articles

$FULMedAI 8/10

H.B. Fuller board rejects unsolicited bid

H.B. Fuller's board rejected an unsolicited bid for its BAS segment, citing a valuation below market precedent and lack of financing details. The board highlighted BAS's 6% organic growth and 10% EBITDA improvement, noting its importance for future earnings. The board also cited operational integration challenges and reaffirmed its strategic priorities, including the Advanced Medical Solutions acquisition and Project Quantum Leap.

$FULMedAI 8/10

H.B. Fuller stock flat as board rejects Ancora’s adhesives bid

H.B. Fuller Co. (NYSE:FUL) shares were unchanged in premarket trading after its board rejected Ancora Holdings Group's $1.2 billion bid for its building adhesives unit, citing undervaluation and lack of growth potential consideration. Ancora criticized the rejection as irrational and emphasized its ability to finance a higher offer. The bid aimed to help H.B. Fuller reduce debt and focus on integrating Advanced Medical Solutions Group Plc.

$FULMed

AMS shareholders approve H.B. Fuller acquisition proposal

H.B. Fuller (NYSE:FUL) said Advanced Medical Solutions Group plc (LSE:AMS) shareholders approved the proposed cash acquisition of AMS. The approval is a milestone toward closing, which H.B. Fuller expects by year end, subject to remaining conditions and regulatory approvals. H.B. Fuller reported 2025 revenue of $3.5B.

$FULMed

Ancora offers up to $1.2bn for an H.B. Fuller business

Activist investor Ancora Holdings proposes an all-cash offer of up to $1.2bn to buy H.B. Fuller’s Building Adhesive Solutions unit, urging divestiture and offering to start due diligence. Ancora, holding over 2% of shares, says it has received no substantive response and may seek board control via a proxy fight. H.B. Fuller shares were down 2.3% intraday.